Evidence map›Paper›PMID 26240314›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

RabGDIα is a negative regulator of interferon-γ-inducible GTPase-dependent cell-autonomous immunity to Toxoplasma gondii.

Jun Ohshima, Miwa Sasai, Jianfa Liu, Kazuo Yamashita, Ji Su Ma, Youngae Lee, Hironori Bando, Jonathan C Howard, Shigeyuki Ebisu, Mikako Hayashi and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in immunology · 2025
    Article
  4. Article
  5. Cell-autonomousLife science alliance · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Jun OhshimaDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan 5650871; Laboratory of Immunoparasitology, World Premier International Research Center Immunology Frontier Research Center, Osaka University, Osaka, Japan 5650871; Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Osaka, Japan 5650871;
Miwa SasaiDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan 5650871; Laboratory of Immunoparasitology, World Premier International Research Center Immunology Frontier Research Center, Osaka University, Osaka, Japan 5650871;
Jianfa LiuDepartment of Pathology and Pathogenic Biology, Medical College of Ningbo University, Ningbo City, China 315211;
Kazuo YamashitaLaboratory of System Immunology, World Premier International Research Center Immunology Frontier Research Center, Osaka University, Osaka, Japan 5650871;
Ji Su MaLaboratory of Immunoparasitology, World Premier International Research Center Immunology Frontier Research Center, Osaka University, Osaka, Japan 5650871;
Youngae LeeDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan 5650871;
Hironori BandoDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan 5650871;
Jonathan C HowardInstitute for Genetics, University of Cologne, Cologne, Germany 50674;
Shigeyuki EbisuDepartment of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Osaka, Japan 5650871;
Mikako HayashiDepartment of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Osaka, Japan 5650871;
Kiyoshi TakedaLaboratory of Mucosal Immunology, World Premier International Research Center Immunology Frontier Research Center, Osaka University, Osaka, Japan 5650871; Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan 5650871;
Daron M StandleyLaboratory of System Immunology, World Premier International Research Center Immunology Frontier Research Center, Osaka University, Osaka, Japan 5650871;
Eva-Maria FrickelDivision of Parasitology, Medical Research Council National Institute of Medical Research, London, United Kingdom SN2 1FL; The Francis Crick Institute, London, United Kingdom NW7 1AA.
Masahiro YamamotoDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan 5650871; Laboratory of Immunoparasitology, World Premier International Research Center Immunology Frontier Research Center, Osaka University, Osaka, Japan 5650871; myamamoto@biken.osaka-u.ac.jp.
Osaka University · JPMedical Research Council · GBNingbo University · CNOsaka International University · JPUniversity of Cologne · DE

Funding

Medical Research Council MC_UP_1202/12Wellcome Trust
6 · The paper itself

Abstract

IFN-γ orchestrates cell-autonomous host defense against various intracellular vacuolar pathogens. IFN-γ-inducible GTPases, such as p47 immunity-related GTPases (IRGs) and p65 guanylate-binding proteins (GBPs), are recruited to pathogen-containing vacuoles, which is important for disruption of the vacuoles, culminating in the cell-autonomous clearance. Although the positive regulation for the proper recruitment of IRGs and GBPs to the vacuoles has been elucidated, the suppressive mechanism is unclear. Here, we show that Rab GDP dissociation inhibitor α (RabGDIα), originally identified as a Rab small GTPase inhibitor, is a negative regulator of IFN-γ-inducible GTPases in cell-autonomous immunity to the intracellular pathogen Toxoplasma gondii. Overexpression of RabGDIα, but not of RabGDIβ, impaired IFN-γ-dependent reduction of T. gondii numbers. Conversely, RabGDIα deletion in macrophages and fibroblasts enhanced the IFN-γ-induced clearance of T. gondii. Furthermore, upon a high dose of infection by T. gondii, RabGDIα-deficient mice exhibited a decreased parasite burden in the brain and increased resistance in the chronic phase than did control mice. Among members of IRGs and GBPs important for the parasite clearance, Irga6 and Gbp2 alone were more frequently recruited to T. gondii-forming parasitophorous vacuoles in RabGDIα-deficient cells. Notably, Gbp2 positively controlled Irga6 recruitment that was inhibited by direct and specific interactions of RabGDIα with Gbp2 through the lipid-binding pocket. Taken together, our results suggest that RabGDIα inhibits host defense against T. gondii by negatively regulating the Gbp2-Irga6 axis of IFN-γ-dependent cell-autonomous immunity.

Indexed as

Gene Expression Regulation, EnzymologicAmino Acid SequenceAnimalsBase SequenceChlorocebus aethiopsDNA PrimersFemaleFibroblastsGTP PhosphohydrolasesGuanine Nucleotide Dissociation InhibitorsInflammationInterferon-gammaLipidsMaleMiceMice, Inbred C57BLDNA PrimersGDP dissociation inhibitor 1GTP PhosphohydrolasesGuanine Nucleotide Dissociation InhibitorsInterferon-gammaLipidscell-autonomous immunityIFN-γ–inducible GTPasenegative regulationToxoplasma gondii

Identifiers

PMID26240314
PMCPMC4547277
OpenAlexW1533251519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.